AASLD Position Paper: The Management of Acute Liver Failure: Update 2011

These recommendations provide a data-supported approach. They are based on the following: 1) Formal review and analysis of recently-published world literature on the topic [Medline search]; 2) American College of Physicians Manual for Assessing Health Practices and Designing Practice Guidelines; 3) guideline policies, including the AASLD Policy on the Development and Use of Practice Guidelines and the AGA Policy Statement on Guidelines;; and 4) the experience of the authors in the specified topic. Intended for use by physicians, the recommendations in this document suggest preferred approaches to the diagnostic, therapeutic and preventive aspects of care. They are intended to be flexible, in contrast to standards of care, which are inflexible policies to be followed in every case. Specific recommendations are based on relevant published information. This document has been designated as a Position Paper, since the topic contains more data based on expert opinion than on randomized controlled trials and is thus not considered to have the emphasis and certainty of a Practice Guideline. Nevertheless, it serves an important purpose of facilitating proper and high level patient care and we have characterized the quality of evidence supporting each recommendation, in accordance with the Practice Guidelines Committee of the AASLD recommendations used for full Practice Guidelines (Table 1) These recommendations are fully endorsed by the AASLD.

[1]  K. Dalhoff,et al.  Serum phosphate is an early predictor of outcome in severe acetaminophen‐induced hepatotoxicity , 2002, Hepatology.

[2]  Uma Maheshwari,et al.  Early indicators of prognosis in fulminant hepatic failure: An assessment of the Model for End‐Stage Liver Disease (MELD) and King's College Hospital Criteria , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  R. Butterworth,et al.  Ammonia‐induced brain edema and intracranial hypertension in rats after portacaval anastomosis , 1994, Hepatology.

[4]  American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers. , 1995, Gastroenterology.

[5]  J. Diamond,et al.  A prospective evaluation of the effect of activated charcoal before oral N-acetylcysteine in acetaminophen overdose. , 1994, Annals of emergency medicine.

[6]  M. Khuroo,et al.  Molecular adsorbent recirculating system for acute and acute‐on‐chronic liver failure: A meta‐analysis , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  R. Bailey,et al.  H2-RECEPTOR ANTAGONISTS AND ANTACIDS IN THE PREVENTION OF ACUTE GASTROINTESTINAL HÆMORRHAGE IN FULMINANT HEPATIC FAILURE Two Controlled Trials , 1977, The Lancet.

[8]  N. Rolando,et al.  Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure , 1993, Hepatology.

[9]  O. James,et al.  CONTROLLED TRIAL OF CYSTEAMINE IN TREATMENT OF ACUTE PARACETAMOL (ACETAMINOPHEN) POISONING , 1976, The Lancet.

[10]  E. Krul,et al.  Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation , 1990, Hepatology.

[11]  T. Mcgarrity,et al.  Herpes Simplex-Induced Fulminant Hepatitis In Adults , 2004, Digestive Diseases and Sciences.

[12]  S. Weinberger,et al.  Thrombocytopenic disorders in critically ill patients. , 2000, American journal of respiratory and critical care medicine.

[13]  J. Furui,et al.  Effects of recombinant human hepatocyte growth factor on the proliferation and function of porcine hepatocytes. , 2000, ASAIO journal.

[14]  B. Kisloff,et al.  Fulminant hepatic failure secondary to congestive heart failure , 1976, The American Journal of Digestive Diseases.

[15]  M. Shearer,et al.  Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. , 2005, Journal of hepatology.

[16]  J. Neuberger,et al.  Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. , 1997, Journal of hepatology.

[17]  A. Czaja,et al.  Diagnosis and treatment of autoimmune hepatitis , 2002, Hepatology.

[18]  S. Vavricka,et al.  The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma. , 2004, Journal of hepatology.

[19]  D. Samuel,et al.  Orthotopic Liver Transplantation in Fulminant and Subfulminant Hepatitis The Paul Brousse Experience , 1995, Annals of surgery.

[20]  D. Amre,et al.  Fulminant hepatic failure secondary to acetaminophen poisoning: A systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation , 2003, Critical care medicine.

[21]  G. Sutherland,et al.  CYSTEAMINE, METHIONINE, AND PENICILLAMINE IN THE TREATMENT OF PARACETAMOL POISONING , 1976, The Lancet.

[22]  A. Gimson,et al.  Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. , 1982, Gut.

[23]  Y. Almog,et al.  Acute liver failure complicating ductal breast carcinoma: two cases and literature review , 2003, Scandinavian journal of gastroenterology.

[24]  D. V. van Thiel,et al.  Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. , 1991, Gastroenterology.

[25]  M. Bonacini,et al.  Recovery from severe hepatitis caused by mushroom poisoning without liver transplantation. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[26]  M. Sorrell,et al.  Brain water and acute liver failure: The emerging role of intracranial pressure monitoring , 1992, Hepatology.

[27]  P. Ott,et al.  Cerebral herniation in patients with acute E liver failure is correlated with arterial ammonia concentration , 1999, Hepatology.

[28]  H. Thaler,et al.  Chemotherapy of Amanita phalloides Poisoning with Intravenous Silibinin , 1983, Human toxicology.

[29]  J. Lake,et al.  Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure , 1992, Hepatology.

[30]  A. Pauwels,et al.  Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. , 1993, Journal of hepatology.

[31]  H. Ring‐Larsen,et al.  Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. , 1981, Gut.

[32]  Koji Hashimoto,et al.  Living-donor liver transplantation for fulminant hepatic failure in adult patients with a left-lobe graft. , 2002, Surgery.

[33]  William M. Lee,et al.  Management of fulminant hepatic failure in the USA: Results from a survey of 14 liver transplant programs , 2001 .

[34]  R. Wiesner,et al.  Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.

[35]  P. Ott,et al.  The effect of increasing blood pressure with dopamine on systemic, splanchnic, and lower extremity hemodynamics in patients with acute liver failure. , 1999, Scandinavian journal of gastroenterology.

[36]  A. Sanyal,et al.  Treatment of fulminant hepatic failure with intravenous prostaglandin E1. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[37]  N. Tygstrup,et al.  High-volume plasmapheresis and acute liver transplantation in fulminant hepatic failure. , 1994, Transplantation proceedings.

[38]  H. King,et al.  EPIPODOPHYLLOTOXIN IN MYCOSIS FUNGOIDES , 1975, The Lancet.

[39]  S. Woolf,et al.  The Expert Panel on Preventive Services: continuing the work of the U.S. Preventive Services Task Force. , 1991, American journal of preventive medicine.

[40]  William M. Lee,et al.  Thrombopoietin in acute liver failure , 2003, Hepatology.

[41]  N. Donaldson,et al.  Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study , 2002, The Lancet.

[42]  L. Seeff,et al.  Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. , 1977, Gastroenterology.

[43]  G. Alexander,et al.  Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure , 1989, Hepatology.

[44]  G. Guyatt,et al.  Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. , 1996, JAMA.

[45]  G. Alexander,et al.  The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure. , 1993, Journal of hepatology.

[46]  L. Blendis,et al.  Frequency and Type of Renal and Electrolyte Disorders in Fulminant Hepatic Failure , 1974, British medical journal.

[47]  W Zidek,et al.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.

[48]  E. Schiff,et al.  Hepatic dysfunction accompanying acute cocaine intoxication. , 1991, Journal of hepatology.

[49]  G. Klintmalm,et al.  Two‐stage total hepatectomy and liver transplantation for acute deterioration of chronic liver disease: A new bridge to transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[50]  R. Del Maestro,et al.  Cerebral and cardiovascular responses to changes in head elevation in patients with intracranial hypertension. , 1983, Journal of neurosurgery.

[51]  Chi-hung Cheng,et al.  Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[52]  Mauro Salizzoni,et al.  Prospective, Randomized, Multicenter, Controlled Trial of a Bioartificial Liver in Treating Acute Liver Failure , 2004, Annals of surgery.

[53]  Randall G. Lee,et al.  Prognostic Value of Abdominal CT Scanning and Hepatic Histopathology in Patients with Acute Liver Failure , 2000, Digestive Diseases and Sciences.

[54]  A. Forbes,et al.  Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. , 1991, BMJ.

[55]  S. Muñoz,et al.  Difficult Management Problems in Fulminant Hepatic Failure , 1993, Seminars in liver disease.

[56]  E. Masini,et al.  A trend in the therapy of Amanita phalloides poisoning , 1976, Archives of Toxicology.

[57]  J. Nerup,et al.  Extracorporeal irradiation of the blood: attempted immunosuppressive treatment of active, non-alcoholic cirrhosis. , 1971, Scandinavian journal of gastroenterology.

[58]  C. Lo,et al.  Right‐lobe live donor liver transplantation improves survival of patients with acute liver failure , 2002, The British journal of surgery.

[59]  Randomised trial of steroid therapy in acute liver failure. Report from the European Association for the Study of the Liver (EASL). , 1979, Gut.

[60]  D. Baker,et al.  Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine. , 2004, Journal of vascular surgery.

[61]  M. Levy,et al.  Comparison of Omeprazole and Ranitidine for Stress Ulcer Prophylaxis , 1997, Digestive Diseases and Sciences.

[62]  G. Auzinger,et al.  The clinical importance of adrenal insufficiency in acute hepatic dysfunction , 2002, Hepatology.

[63]  M. Khuroo,et al.  Aetiology and prognostic factors in acute liver failure in India , 2003, Journal of viral hepatitis.

[64]  J. Beaubien,et al.  FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: A report of four cases , 2005, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[65]  J. Wendon,et al.  Circulatory, Respiratory, Cerebral, and Renal Derangements in Acute Liver Failure: Pathophysiology and Management , 1996, Seminars in liver disease.

[66]  R. Hughes,et al.  Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure , 1996, Hepatology.

[67]  N. Finlayson The Adverse Effects of Drugs on the Liver , 1973, The British journal of clinical practice.

[68]  Christian Gluud,et al.  Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. , 2003, JAMA.

[69]  K. Boudjema,et al.  Auxiliary Liver Transplantation and Bioartificial BridgingProcedures in Treatment of Acute Liver Failure , 2002, World Journal of Surgery.

[70]  M. Gebel,et al.  Which is the best surgery for budd‐chiari syndrome: Venous decompression or liver transplantation? a single‐center experience with 50 patients , 1995, Hepatology.

[71]  G. Levy,et al.  Treatment of fulminant viral hepatic failure with prostaglandin E , 1991, Digestive Diseases and Sciences.

[72]  B. Shaw,et al.  The American Experience with Transplantation for Acute Liver Failure , 1996, Seminars in liver disease.

[73]  T. Starzl,et al.  Liver Transplantation for Fulminant Hepatic Failure , 1985, Seminars in liver disease.

[74]  R. Bell,et al.  Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure , 1991, Hepatology.

[75]  J. Lake,et al.  Determining prognosis in patients with fulminant hepatic failure: When you absolutely, positively have to know the answer , 1995, Hepatology.

[76]  P. Hopton,et al.  The effect of N‐acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure , 1998, Hepatology.

[77]  G. Vanscoy,et al.  Failure of N‐Acetylcysteine to reduce alpha amanitin toxicity , 1992, Journal of applied toxicology : JAT.

[78]  V. Bhatia,et al.  Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure--a controlled clinical trial. , 2004, Journal of hepatology.

[79]  A. Detsky,et al.  Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. , 1989, Gastroenterology.

[80]  P. Hayes,et al.  Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy , 2004, Hepatology.

[81]  R. Williams,et al.  Maternal and perinatal outcome in severe pregnancy‐related liver disease , 1997, Hepatology.

[82]  P. Ott,et al.  Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. , 2000, Gastroenterology.

[83]  K. Boudjema,et al.  Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT Study Group. European Auxiliary Liver Transplant Registry. , 1999, Journal of hepatology.

[84]  Andreas H Kramer,et al.  Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group , 2007, Critical care medicine.

[85]  S. A. Kucharski Fulminant hepatic failure. , 1993, Critical care nursing clinics of North America.

[86]  J. Neuberger,et al.  Recovery despite impaired cerebral perfusion in fulminant hepatic failure , 1994, The Lancet.

[87]  M. Schilsky Diagnosis and treatment of Wilson's disease , 2002, Pediatric transplantation.

[88]  P. Hayes,et al.  Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. , 2004, Gastroenterology.

[89]  E. Torres,et al.  Steroid therapy in fulminant hepatic failure secondary to autoimmune hepatitis. , 1998, Puerto Rico health sciences journal.

[90]  D. Falkenhagen,et al.  Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. , 1999, Artificial organs.

[91]  N. Chatauret,et al.  Mild Hypothermia Prevents Cerebral Edema and CSF Lactate Accumulation in Acute Liver Failure , 2001, Metabolic Brain Disease.

[92]  B. Combes,et al.  A controlled trial of steroid therapy in massive hepatic necrosis. , 1974, The American journal of gastroenterology.

[93]  William M. Lee,et al.  Acetaminophen toxicity in an urban county hospital. , 1997, The New England journal of medicine.

[94]  D. Samuel,et al.  Liver transplantation in fulminant and subfulminant hepatitis , 1989 .

[95]  G. Guyatt,et al.  A Comparison of Sucralfate and Ranitidine for the Prevention of Upper Gastrointestinal Bleeding in Patients Requiring Mechanical Ventilation , 1999 .

[96]  Alistair Lee,et al.  Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure , 1999, The Lancet.

[97]  R Williams,et al.  Early indicators of prognosis in fulminant hepatic failure. , 1989, Gastroenterology.

[98]  M. Tenenbein,et al.  How Long After Drug Ingestion Is Activated Charcoal Still Effective? , 2001, Journal of toxicology. Clinical toxicology.

[99]  M. Rosner,et al.  Cerebral perfusion pressure: management protocol and clinical results. , 1995, Journal of neurosurgery.

[100]  A. Gimson,et al.  Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. , 1988, Gastroenterology.

[101]  G. Knapp,et al.  Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985) , 1988, The New England journal of medicine.

[102]  Michael C. Richardson,et al.  A survey of liver transplantation from living adult donors in the United States. , 2003, The New England journal of medicine.

[103]  I M Sauer,et al.  Clinical extracorporeal hybrid liver support – phase I study with primary porcine liver cells , 2003, Xenotransplantation.

[104]  J. Farrell,et al.  The Management of Fulminant Hepatic Failure , 2001 .

[105]  F. Larsen,et al.  Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. , 2007, Journal of Hepatology.

[106]  V. Beral,et al.  PREGNANCY OUTCOME IN INSULIN-DEPENDENT DIABETICS WITH THYROID DISEASE OR PERNICIOUS ANAEMIA , 1984, The Lancet.

[107]  M. Hudson,et al.  Metastatic breast carcinoma presenting as acute liver failure and portal hypertension , 2002, American Journal of Gastroenterology.

[108]  K. Boudjema,et al.  Auxiliary versus orthotopic liver transplantation for acute liver failure , 1999 .

[109]  A. Davenport,et al.  Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure , 1993, Critical care medicine.

[110]  W. Zidek,et al.  N-Acetylcysteine in nephrology; contrast nephropathy and beyond , 2004, Current opinion in nephrology and hypertension.

[111]  J. Tredger,et al.  Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. , 1992, Gut.

[112]  A. Pollok,et al.  Complications of intracranial pressure monitoring in fulminant hepatic failure , 1993, The Lancet.

[113]  G. Trimarchi,et al.  Use of Acetylcysteine as the Life-saving Antidote in Amanita phalloides (Death Cap) Poisoning , 1999, Arzneimittelforschung.

[114]  R. Scobey,et al.  Intracranial pressure during epileptic seizures. , 1984, Electroencephalography and clinical neurophysiology.

[115]  N. Chatauret,et al.  Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure , 2000, Hepatology.

[116]  J. Whiting,et al.  ABO‐incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: Evidence for accommodation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[117]  B. Combes,et al.  Cerebral edema: a major complication of massive hepatic necrosis. , 1971, Gastroenterology.

[118]  S. Munoz Hypothermia may impair hepatic regeneration in acute liver failure. , 2005, Gastroenterology.

[119]  M. Moritz,et al.  Perioperative management of fulminant and subfulminant hepatic failure with therapeutic plasmapheresis. , 1989, Transplantation proceedings.

[120]  S. Uemoto,et al.  Living donor liver transplantation for fulminant hepatic failure. , 2000, Transplantation.

[121]  L. Weinstein Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. , 1982, American journal of obstetrics and gynecology.

[122]  G. Alexander,et al.  Effects of vasopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in fulminant hepatic failure , 1992, Hepatology.

[123]  J. Millis,et al.  Technology Insight: liver support systems , 2005, Nature Clinical Practice Gastroenterology &Hepatology.

[124]  B. Hoffman,et al.  Predicting survival in fulminant hepatic failure using serum gc protein concentrations , 1995, Hepatology.

[125]  Risk factors for gastrointestinal bleeding in critically ill patients , 1994 .

[126]  J. Muntané,et al.  Acute liver failure caused by diffuse hepatic melanoma infiltration. , 2002, Journal of hepatology.

[127]  R. Strauss,et al.  Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[128]  S R Ash,et al.  Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT). , 1992, The International journal of artificial organs.

[129]  W. Knaus,et al.  The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. , 1991, Chest.

[130]  B. McMahon,et al.  [AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]. , 2004, Romanian journal of gastroenterology.

[131]  B. Celli,et al.  Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. , 1987, The New England journal of medicine.

[132]  J. Wendon,et al.  Severe hepatic dysfunction in pregnancy. , 2002, QJM : monthly journal of the Association of Physicians.

[133]  M. Dew,et al.  The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor. , 2006, Transplantation.

[134]  J. K. Kim,et al.  Peritoneal dialysis in diabetic patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[135]  A. Blei The impact of Hepatology , 2004, Hepatology.

[136]  G. Germann,et al.  The value of early enteral nutrition in the prophylaxis of stress ulceration in the severely burned patient. , 1997, Burns : journal of the International Society for Burn Injuries.

[137]  W. Meyers,et al.  Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. , 1994, The New England journal of medicine.

[138]  G. Guyatt,et al.  A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. , 1998, The New England journal of medicine.

[139]  Y. Chawla,et al.  Prognostic Evaluation of Early Indicators in Fulminant Hepatic Failure by Multivariate Analysis , 1998, Digestive Diseases and Sciences.

[140]  G. Alexander,et al.  Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. , 1991, The New England journal of medicine.

[141]  H. Popper,et al.  Progress in Liver Diseases , 1962 .

[142]  G. Zuckerman,et al.  Prophylactic therapy for stress ulcer bleeding: a reappraisal. , 1987, Annals of internal medicine.

[143]  N. Kneteman,et al.  ABO‐incompatible liver transplantation for critically ill adult patients , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[144]  D. Schuppan,et al.  Herbal hepatotoxicity. , 2005, Journal of hepatology.

[145]  H. Reines,et al.  Stress ulcers and organ failure in intubated patients in surgical intensive care units. , 1992, Annals of surgery.

[146]  K. Böker,et al.  Akutes Leberversagen , 2001, Der Internist.

[147]  William M. Lee,et al.  Gc‐globulin and prognosis in acute liver failure , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[148]  P. Ott,et al.  Cerebral microdialysis in patients with fulminant hepatic failure , 2002, Hepatology.

[149]  Roger Williams,et al.  Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. , 1986, Journal of hepatology.

[150]  Y. Itai,et al.  Fulminant hepatic failure: observation with serial CT. , 1997, Radiology.

[151]  K. Soma,et al.  Acute liver failure following intravenous methamphetamine. , 2002, Veterinary and human toxicology.

[152]  M. Metzler,et al.  A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. , 1998, The Journal of trauma.

[153]  B. McMahon,et al.  Chronic hepatitis B: Update of recommendations , 2004, Hepatology.

[154]  Shawn M Sumida,et al.  Efficacy of superactivated charcoal administered late (3 hours) after acetaminophen overdose. , 2003, The American journal of emergency medicine.

[155]  G. Knudsen,et al.  S‐100b and neuron‐specific enolase in patients with fulminant hepatic failure , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[156]  H. Zimmerman,et al.  Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure , 1995, Hepatology.

[157]  B. Gazzard,et al.  Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. , 1975, Gut.

[158]  R. Busuttil,et al.  Amanita poisoning: treatment and the role of liver transplantation. , 1989, The American journal of medicine.

[159]  D. Kerr,et al.  Paracetamol-induced acute renal failure in the absence of fulminant liver damage. , 1982, British medical journal.

[160]  J. Jhang,et al.  Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease , 2007, Journal of clinical apheresis.

[161]  J. O'grady Blood cell disorders after liver transplantation. , 1992, Journal of hepatology.

[162]  Sumner Hw,et al.  Metastatic carcinoma presenting as fulminant hepatic failure. , 1979 .

[163]  R. Wiesner,et al.  Acute liver failure: results of a 5-year clinical protocol. , 1995, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[164]  K. Ishak,et al.  Acute fatty liver of pregnancy: A clinicopathologic study of 35 cases , 1985, Hepatology.

[165]  G. Alexander,et al.  Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine , 1990, The Lancet.

[166]  J. Burnell,et al.  Acute hepatic coma treated by cross-circulation or exchange transfusion. , 1967, The New England journal of medicine.

[167]  J. Rakela,et al.  A double-blinded, randomized trial of hydrocortisone in acute hepatic failure , 1991, Digestive Diseases and Sciences.

[168]  R. Balkrishnan,et al.  Risk Stratification of Adult Patients Undergoing Orthotopic Liver Transplantation for Fulminant Hepatic Failure , 2006, Transplantation.

[169]  W. Knaus The APACHE III Prognostic System , 1992 .

[170]  G. Alexander,et al.  Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. , 1990, BMJ.

[171]  J. Manzano,et al.  Stress‐induced gastroduodenal lesions and total parenteral nutrition in critically ill patients: Frequency, complications, and the value of prophylactic treatment. A prospective, randomized study , 1991, Critical care medicine.

[172]  P. Ott,et al.  Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure , 2001, American Journal of Gastroenterology.

[173]  William M. Lee,et al.  Viral hepatitis-related acute liver failure. , 2003 .

[174]  J. Avorn Acetaminophen toxicity in an urban county hospital. , 1998, The New England journal of medicine.

[175]  R. Williams,et al.  Neurological sequelae in patients recovered from fulminant hepatic failure. , 1987, Gut.

[176]  S. Sarin,et al.  Maternal and Fetal Outcomes in Pregnant Women with Acute Hepatitis E Virus Infection , 2007, Annals of Internal Medicine.

[177]  S. Uemoto,et al.  Liver failure following living donor liver transplantation for fulminant hepatic failure. , 2000, Transplantation proceedings.

[178]  E. Wijdicks,et al.  Propofol to control intracranial pressure in fulminant hepatic failure. , 2002, Transplantation proceedings.

[179]  William M. Lee,et al.  Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[180]  M. Schilsky,et al.  A practice guideline on Wilson disease , 2003, Hepatology.

[181]  R. Williams,et al.  Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases , 1998, Gut.

[182]  N. Buckley,et al.  Paracetamol (acetaminophen) poisoning. , 2004, Clinical evidence.

[183]  J. Bernuau Selection for emergency liver transplantation. , 1993, Journal of hepatology.

[184]  F. Larsen,et al.  Cerebral oxygenation determined by near-infrared spectrophotometry in patients with fulminant hepatic failure. , 2003, Journal of hepatology.

[185]  R. Chang,et al.  Earlier identification of patients at risk from acetaminophen-induced acute liver failure. , 1998, Critical care medicine.

[186]  J. Hoofnagle,et al.  Fulminant Hepatic Failure : Summary of a Workshop , 2017 .

[187]  L. Alba,et al.  Lactulose therapy in acute liver failure , 2002 .

[188]  A. Schubert,et al.  Side Effects of Mild Hypothermia , 1995, Journal of neurosurgical anesthesiology.

[189]  H. Moriwaki,et al.  High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis. , 2000, The Journal of infectious diseases.

[190]  S. Bickston,et al.  Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[191]  P. Hayes,et al.  Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure , 2000, Transplantation.

[192]  R. Pichlmayr,et al.  Management of emergencies before and after liver transplantation by early total hepatectomy. , 1993, Transplantation proceedings.

[193]  P. Ott,et al.  Haemodynamic changes after high‐volume plasmapheresis in patients with chronic and acute liver failure , 1997, European Journal of Gastroenterology and Hepathology.

[194]  D. Ganger,et al.  Brain edema in rabbits with galactosamine-induced fulminant hepatitis. Regional differences and effects on intracranial pressure. , 1986, Gastroenterology.

[195]  William M. Lee,et al.  Viral Hepatitis-Related Acute Liver Failure , 2003, American Journal of Gastroenterology.

[196]  A. Blei,et al.  Pathogenesis of Hepatic Encephalopathy in Acute Liver Failure , 2003, Seminars in liver disease.

[197]  H. Rosen Hepatitis B and C in the liver transplant recipient: Current understanding and treatment , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[198]  J. Wendon,et al.  Subclinical Seizure Activity and Prophylactic Phenytoin Infusion in Acute Liver Failure: A Controlled Clinical Trial , 2000, Hepatology.

[199]  M. Manns,et al.  Review Article: Clinical Experience With Prometheus , 2006, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[200]  Roger Williams,et al.  The systemic inflammatory response syndrome in acute liver failure , 2000, Hepatology.

[201]  G. Auzinger,et al.  The effects of supraphysiological doses of corticosteroids in hypotensive liver failure , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[202]  G. Knudsen,et al.  Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. , 1998, Journal of hepatology.

[203]  R Williams,et al.  Pilot‐controlled trial of the extracorporeal liver assist device in acute liver failure , 1996, Hepatology.

[204]  J. Marsh,et al.  Successful retransplantation after a 48-hour anhepatic state. , 1993, Transplantation proceedings.

[205]  M. Palmieri,et al.  A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. , 1996, Critical care medicine.

[206]  S. Saab,et al.  Liver Transplantation for Fulminant Hepatic Failure: Experience With More Than 200 Patients Over a 17-Year Period , 2003 .

[207]  T. Mcgarrity,et al.  Herpes simplex-induced fulminant hepatitis in adults: a call for empiric therapy. , 2000, Digestive diseases and sciences.

[208]  G. Alexander,et al.  Fungal infection: a common, unrecognised complication of acute liver failure. , 1991, Journal of hepatology.

[209]  R. Andrade,et al.  Drug-induced hepatotoxicity , 2003, The New England journal of medicine.

[210]  N. Secher,et al.  Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high‐volume plasmapheresis in fulminant hepatic failure , 1996, European journal of gastroenterology & hepatology.

[211]  G. Auzinger,et al.  The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure , 2004, Hepatology.

[212]  D. Valla,et al.  Portal hypertension and ascites in acute hepatitis: Clinical, hemodynamic and histological correlations , 1989, Hepatology.

[213]  Y. Chawla,et al.  Effect of renal dysfunction in fulminant hepatic failure. , 2000, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[214]  M. Gaddis,et al.  Oral ranitidine as prophylaxis for gastric stress ulcers in intensive care unit patients: Serum concentrations and cost comparisons , 1993, Critical care medicine.

[215]  M. Löhr,et al.  Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. , 1999, Artificial organs.

[216]  R. I. Hansen,et al.  Pig liver perfusion in the treatment of acute hepatic failure. , 1971, Scandinavian journal of gastroenterology. Supplement.

[217]  William M. Lee,et al.  Infection and the progression of hepatic encephalopathy in acute liver failure. , 2003, Gastroenterology.

[218]  William M. Lee,et al.  Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States , 2002, Annals of Internal Medicine.

[219]  N. Rolando,et al.  Prospective study of bacterial infection in acute liver failure: An analysis of fifty patients , 1990, Hepatology.

[220]  G. Mazariegos,et al.  Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[221]  G. Auzinger,et al.  Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure , 2007, Hepatology.

[222]  F. Larsen,et al.  MELD score as a predictor of liver failure and death in patients with acetaminophen‐induced liver injury , 2007, Hepatology.

[223]  J. Patzer,et al.  Intracranial pressure observations in a canine model of acute liver failure supported by a bioartificial liver support system. , 2007, Artificial organs.

[224]  S. Rapior,et al.  Treatment of Amatoxin Poisoning: 20-Year Retrospective Analysis , 2002, Journal of toxicology. Clinical toxicology.

[225]  STRESS ULCER PROPHYLAXIS IN CRITICALLY ILL PATIENTS , 1989, The Lancet.

[226]  E. Brommer,et al.  Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage , 1986, Hepatology.

[227]  M. Welte,et al.  N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: Results of a prospective, randomized, double-blind study , 2000, Critical care medicine.

[228]  C. Graves,et al.  Herpes simplex hepatitis in pregnancy: a case report and review of the literature. , 1999, Obstetrical & gynecological survey.

[229]  F. Nath,et al.  The effect of mannitol on cerebral white matter water content. , 1986, Journal of neurosurgery.

[230]  Z. Younossi,et al.  Mushroom poisoning—from diarrhea to liver transplantation , 2001, American Journal of Gastroenterology.

[231]  T. A. Dalton,et al.  Hepatotoxicity associated with sustained-release niacin. , 1992, The American journal of medicine.

[232]  Thomas M van Gulik,et al.  ASSESSMENT OF THE AMC-BIOARTIFICIAL LIVER IN THE ANHEPATIC PIG1 , 2002, Transplantation.

[233]  M. Black,et al.  Acetaminophen hepatotoxicity. , 1980, Gastroenterology.

[234]  D. Samuel,et al.  Emergency liver transplantation for fulminant hepatitis. , 1987, Annals of internal medicine.